Related Experiment Video
Updated: Jul 17, 2026
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Identification of Novel PKC Alpha Inhibitors: Structural and Functional Characterization Using In Silico and In Vitro
Shiven Das1, Devika S Kumar2, Arunasree Kalle2
1Bridgewater-Raritan High School, 600 Garretson, Bridgewater, New Jersey, 08807, United States of America.
Introduction:
Protein Kinase C alpha (PKCα), a key regulator of cellular signaling, is frequently dysregulated in breast cancer. Despite its clinical relevance, there is a dearth of selective and safe PKCα inhibitors. This study aims to identify and characterize novel PKCα inhibitors using computational and experimental methodologies.
Methods:
A structure-based virtual screening of the Enamine Hinge Binders Library against the PKCα receptor (PDB ID: 3IW4) was performed using the Glide module of Schrödinger Suite. Analysis of docking scores, protein-ligand interactions, binding free energies, and ADMET profiles helped identify lead candidates. The stability of protein-ligand complexes was confirmed using MD simulations. The functional activity of identified candidates was validated using a kinase assay, and cell death was analyzed using an MTT assay on breast cancer cell lines.
Results:
Compounds Z3077775938 (P1) and Z22177390 (P2) exhibited strong binding and stability within the hinge-binding region of PKCα and showed favorable drug-likeness profiles. Structural analysis revealed P1 and P2 as novel scaffolds. The kinase assay revealed dosedependent inhibition of PKCα's ATP-binding activity with IC50 values of P1 and P2 as 0.92 nM and 15.27 nM, respectively. Both compounds induced dose-dependent cytotoxicity in breast cancer cells.
Discussion:
This study identified two novel, structurally diverse PKCα inhibitors. Their low IC50 values and dose-dependent cytotoxicity, as observed in both ER+ and triple-negative breast cancer cell lines, validate their functional efficacy and highlight therapeutic potential for breast cancer treatment.
Conclusion:
Overall, this study identified two PKCα inhibitors that provide a foundation for further optimization as selective therapeutic agents in PKCα-driven malignancies.
Insights
Researchers identified two novel compounds that inhibit Protein Kinase C alpha (PKCα), a key target in breast cancer. These potent PKCα inhibitors show promise for developing new breast cancer therapies.
Area of Science:
- Biochemistry and Molecular Biology
- Medicinal Chemistry
- Cancer Research
Background:
- Protein Kinase C alpha (PKCα) is a critical regulator of cellular signaling pathways.
- Dysregulation of PKCα is frequently observed in various types of breast cancer.
- There is an unmet need for selective and safe PKCα inhibitors for therapeutic applications.
Purpose of the Study:
- To identify and characterize novel inhibitors of Protein Kinase C alpha (PKCα).
- To utilize computational and experimental approaches for drug discovery.
- To evaluate the potential of identified compounds as therapeutic agents for breast cancer.
Main Methods:
- Structure-based virtual screening of a chemical library against the PKCα receptor.
- Molecular docking, binding free energy calculations, and ADMET profiling.
- Molecular dynamics simulations for complex stability, kinase assays, and MTT assays for cytotoxicity.
Main Results:
- Two novel compounds, P1 and P2, with distinct scaffolds demonstrated strong binding and stability with PKCα.
- P1 and P2 exhibited potent inhibition of PKCα's ATP-binding activity with low nanomolar IC50 values (0.92 nM and 15.27 nM, respectively).
- Both compounds induced dose-dependent cytotoxicity in ER+ and triple-negative breast cancer cell lines.
Conclusions:
- This study successfully identified two novel, structurally diverse, and potent PKCα inhibitors.
- The identified compounds possess significant therapeutic potential for breast cancer treatment.
- These inhibitors provide a foundation for developing selective agents targeting PKCα-driven malignancies.
Related Concept Videos
02:04Protein-protein Interfaces
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:29Pharmacogenomics: Identification of New Drug Targets